Webinars

Hospital Formulary Insights for Anti-Infectives: Assessing Formulary Decision-Making and Formulary Uptake of Key Brands in the United States

11/9/2011

This 30 minute webinar will be held on November 17, 2011. This webinar is only available to purchasers of this study. Please contact us to learn how you can purchase this study, attend the webinar and have full access to the authors of this study.

U.S. Physician Perspectives on the Launch of Teflaro and Dificid: Where Will These Novel Therapies Fit Into The Treatment Algorithm for Serious Bacterial Infections? - On Demand

10/4/2011

In its LaunchTrends® Institutional studies of Teflaro and Dificid, Arlington Medical Resources (AMR) and BioTrends Research Group surveyed 102 infectious disease (ID) specialists and internists to assess their awareness, trial, and usage of each of these products.

This webinar was held on October 4, 2011. Click here to access the recorded playback of this webinar.

Hospital Antibiotics: What are the Leading Indications and Preferred Therapies for the Treatment of Key Pathogens, the Unmet Needs and the Drivers of Formulary Decisions? - On Demand

5/31/2011

Based on Decision Resources' U.S. Physician & Payer Forum report entitled Hospital Anti-Infectives: Insights on the Uptake, Formulary Inclusion, and Reimbursement of Emerging Antibiotics in the U.S. and our Hospital Insight Series: Hospital Anti-Infectives report, Decision Resources, Inc. is offering this exclusive webinar.

This webinar was held on June 1, 2011. Contact us to learn how you can purchase both of these reports and access the recorded event.

Click here to view the invite.

The Demise of Anticoagulant Bridging: How Novel Agents Such As Pradaxa and Xarelto Represent a New Paradigm in Transitioning Patients From Injectable to Oral Anticoagulants- On Demand

12/14/2010

This exclusive webinar is based on Arlington Medical Resources’ recently launched European Anticoagulant Market Guide.

This webinar was held on December 20, 2010. Contact us to learn how you can access the recorded event.

Click here to view the invite.

Is Clostridium Difficile the New MRSA? Opportunities for Antibiotic Drug Development - On Demand

9/29/2009

Based on the Decision Resources' August 2009 report, Hospital Anti-Infectives Insight Series: Clostridium Difficile, Arlington Medical Resources (AMR) and Decision Resources are offering an exclusive, in-depth webinar entitled Is Clostridium Difficile the New MRSA? Opportunities for Antibiotic Drug Development. Because this webinar will feature major report findings, it is ONLY available to purchasers of this report.

This webinar was held on September 29, 2009 and is only available to purchasers of this report. Contact us to learn how you can purchase this report and access the recorded playback.

Click here to view the invite.

Hospital Anti-Infectives Insight Series: Analyzing Prescribing Trends and Emerging Therapies in the Hospital Antibiotic Market

5/27/2009

This presentation is based on our Hospital Anti-Infectives Insight Series which analyzes hospital antibiotic prescribing patterns using AMR’s comprehensive and highly detailed clinical data in conjunction with Decision Resources’ disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the reasons behind physicians’ product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

This webinar was held on June 17, 2009. Click here to access the recorded playback.
Click here to view the invite.

News & Events

Decision Resources Group companies include: